Page last updated: 2024-08-23

bromocriptine and Night Blindness

bromocriptine has been researched along with Night Blindness in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, EH; Gardella, A; Kefalov, VJ; Leinonen, H; Palczewski, K	1

Other Studies

1 other study(ies) available for bromocriptine and Night Blindness

Article	Year
A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness. Investigative ophthalmology & visual science, 2019, 04-01, Volume: 60, Issue:5 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Arrestins; Bromocriptine; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 1; Light; Metoprolol; Mice; Night Blindness; Tamsulosin; Transducin; United States; United States Food and Drug Administration	2019

Article

Year

A Mixture of U.S. Food and Drug Administration-Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness.

Investigative ophthalmology & visual science, 2019, 04-01, Volume: 60, Issue:5

Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagonists; Animals; Arrestins; Bromocriptine; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 1; Light; Metoprolol; Mice; Night Blindness; Tamsulosin; Transducin; United States; United States Food and Drug Administration

2019